Skip to content
Screener

LB Pharmaceuticals Inc LBRX Q2 2026 earnings

Reported August 11, 2026 · Before market open

EPS-$1.71Miss by $0.91
EPS estimate-$0.80

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$1.61

Versus estimates

Diluted EPS

Q2 2026-$1.71Miss by $0.91
Q1 2026-$0.67Beat by $0.08Q4 2025-$0.45In lineQ3 2025-$0.61Miss by $0.04

FAQ

When did LB Pharmaceuticals Inc report Q2 2026 earnings?
LB Pharmaceuticals Inc (LBRX) reported Q2 2026 earnings on August 11, 2026 before market open.
What were LB Pharmaceuticals Inc's Q2 2026 revenue and EPS?
LB Pharmaceuticals Inc reported eps of $-1.71 for Q2 2026.
Did LB Pharmaceuticals Inc beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.80 by $0.91.
Where can I find LB Pharmaceuticals Inc's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-343479) and the 10-Q periodic report (0001193125-26-343490) directly on SEC EDGAR. The filing index links above go to sec.gov.